Furthermore, a study focusing on patients with type 1 diabetes identified a "fast-glycator phenotype," characterized by a lower glucose management indicator (GMI) compared to HbA1c levels.

Additionally, the model occasionally failed to prioritize important clinical metrics such as time in range or GMI when summarizing overall glucose control. Despite these limitations, GPT-4 ...